Dextromitadine
Reading File
Finding Sources
Searching the Web
dextromitadine drug
Finding Sources
Reading File
Reading File
I now have enough information to give a thorough answer. "Dextromitadine" is not a real drug - it is almost certainly a misspelling of dexmedetomidine. Here is what the textbooks say:
"Dextromitadine" - Did You Mean Dexmedetomidine?
There is no drug called dextromitadine in any pharmacological database, medical textbook, or drug registry. This appears to be a misspelling of dexmedetomidine (brand name: Precedex), which is the most phonetically similar real drug.
Dexmedetomidine
What It Is
Dexmedetomidine is a highly selective alpha-2 (α2) adrenergic agonist used primarily for sedation and analgesia. It is the active S-enantiomer of medetomidine, a compound used in veterinary medicine. It is water-soluble and available as a parenteral (IV) formulation.
- Katzung's Basic and Clinical Pharmacology, 16th Edition
Mechanism of Action
It acts by binding to α2-adrenoceptors in the central nervous system:
- Sedation/hypnosis: stimulation of α2 receptors in the locus coeruleus
- Analgesia: action at the spinal cord level
- The sedation it produces resembles physiologic sleep (unlike benzodiazepines or propofol), as it activates endogenous sleep pathways
Pharmacokinetics
- Undergoes rapid hepatic metabolism (N-methylation and hydroxylation, then conjugation)
- Metabolites excreted in urine and bile
- Elimination half-time is short, but the context-sensitive half-time rises significantly with prolonged infusion: ~4 minutes after a 10-minute infusion vs. ~250 minutes after an 8-hour infusion
Organ System Effects
CNS:
- Sedation, anxiolysis, amnesia
- Likely decreases cerebral blood flow without significant changes in ICP or CMRO2
- Can lead to tolerance and dependence with prolonged use
Cardiovascular:
- Bradycardia and decreased blood pressure (expected due to α2-mediated sympatholysis)
- When combined with sympatholytic or cholinergic agents, there is a high risk for significant hemodynamic compromise
Respiratory:
- Preserves spontaneous respiration even at high concentrations - a key advantage over opioids and other sedatives
- No significant cardiorespiratory compromise at standard doses
Clinical Uses
- ICU sedation - patients can be easily aroused while still sedated (cooperative sedation)
- Procedural sedation - useful during painful procedures, often combined with opioids
- Perioperative adjunct - reduces opioid requirements in surgery (e.g., abdominal hysterectomy, cholecystectomy)
- Premedication - reduces anesthetic requirements, particularly fentanyl dosing
- Off-label in pediatrics - intranasal dexmedetomidine (1 mcg/kg) used for preoperative anxiolysis
- Regional anesthesia adjunct - used perineural and as a neuraxial adjunct
Special Populations
- Patients with renal impairment experience a longer-lasting sedative effect due to reduced protein binding
Key Advantage Over Other Sedatives
Unlike propofol, benzodiazepines, or barbiturates, dexmedetomidine produces deep sedation without respiratory depression and allows patients to be easily roused - making it particularly valuable when ongoing neurological assessment is needed.
If you were asking about a different drug (e.g., desloratadine, dextromethadone, dextromethorphan, or something else), please clarify and I can provide the correct information.
This is a shared conversation. Sign in to Orris to start your own chat.